Tenet Healthcare Corporation $THC Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC reduced its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 33.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,535 shares of the company’s stock after selling 31,900 shares during the quarter. Gabelli Funds LLC’s holdings in Tenet Healthcare were worth $12,626,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of THC. Triumph Capital Management acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at about $29,000. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $32,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at about $35,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Stock Down 0.9%

THC stock opened at $190.64 on Wednesday. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21. The company has a market capitalization of $16.42 billion, a price-to-earnings ratio of 9.91, a price-to-earnings-growth ratio of 1.27 and a beta of 1.30. The firm’s 50-day moving average is $197.55 and its two-hundred day moving average is $203.44. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. During the same period in the previous year, the firm earned $4.36 EPS. Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts forecast that Tenet Healthcare Corporation will post 17.64 earnings per share for the current fiscal year.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Zacks Research raised its FY2027 earnings estimate for Tenet Healthcare to $17.17 per share from $16.35, which reinforces the view that profitability remains solid and supports the stock’s valuation. Article Title
• Positive Sentiment: Wall Street commentary also pointed to a roughly 26% implied upside based on average analyst price targets, which may be helping offset some near-term weakness. Article Title
• Neutral Sentiment: Analysts also nudged some near-term quarterly estimates higher, including Q3 2027 and Q4 2027, but the changes were modest and not enough on their own to drive a major move. Article Title
• Negative Sentiment: Offsetting that optimism, Zacks cut its Q2 2027 EPS estimate from $4.75 to $4.17, suggesting some near-term earnings pressure. Article Title
• Negative Sentiment: Tenet is also involved in a legal dispute with Leapfrog over hospital ratings and legal fees, including a request that Leapfrog pay $10.5 million, which keeps litigation risk in focus. Article Title

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 46,517 shares of company stock worth $10,943,111. 0.97% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on THC shares. Jefferies Financial Group lifted their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Royal Bank Of Canada cut their price objective on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Weiss Ratings reiterated a “buy (b-)” rating on shares of Tenet Healthcare in a research report on Friday, March 27th. Mizuho lifted their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research report on Thursday, March 12th. Finally, Morgan Stanley set a $254.00 price objective on shares of Tenet Healthcare in a research report on Friday, May 1st. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $244.16.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.